Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I study of TAK-169 in relapsed or refractory multiple myeloma underway

Jan. 22, 2020

Signs of efficacy seen with ONCOS-102 and chemotherapy in mesothelioma trial

Jan. 22, 2020

Tepezza approved in the U.S. for thyroid eye disease

Jan. 22, 2020

TNFAIP1 is a tumor suppressor in heptocellular carcinoma

Jan. 22, 2020

Boehringer Ingelheim presents GPR142 agonists

Jan. 22, 2020

DFH Therapeutics and HHS describe betulinic acid derivatives for HIV infection

Jan. 22, 2020

AlzeCure Pharma discloses new Trk-A and Trk-B modulators

Jan. 22, 2020

Yale University divulges let-7 microRNA-activating compounds for endometriosis

Jan. 22, 2020

Catalent patents decorin-containing products for cancer

Jan. 22, 2020

Multitrait analysis predicts glaucoma susceptibility, progression

Jan. 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...